BioSpace News Archive

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that management will virtually participate in the 25th Annual Needham Growth Conference with a fireside chat on January 12, 2023, at 3:00p.m. ET.

CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2022, as well as key clinical and corporate developments.

TG Therapeutics, Inc. announced the U.S. Food and Drug Administration has approved BRIUMVI™, for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference.

Glaukos Corporation announced that its management is scheduled to participate in the 41st Annual J.P Morgan Healthcare Conference on Tuesday, January 10, 2023, at 5:15 p.m. PT in San Francisco, CA.

ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, announced that Susan Altschuller, PhD, Senior Vice President and Chief Financial Officer, is on leave under the Family and Medical Leave Act and will not continue employment with ImmunoGen at the conclusion of her leave.